CAPTRUST Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,953
| Closed | -$399K | – | 2357 |
|
|
2024
Q4 | $399K | Sell |
16,953
-2,012
| -11% | -$47.4K | ﹤0.01% | 1735 |
|
|
2024
Q3 | $485K | Buy |
+18,965
| New | +$485K | ﹤0.01% | 1587 |
|
|
2024
Q2 | – | Sell |
-13,565
| Closed | -$390K | – | 2201 |
|
|
2024
Q1 | $390K | Sell |
13,565
-4,040
| -23% | -$116K | ﹤0.01% | 1622 |
|
|
2023
Q4 | $578K | Sell |
17,605
-476
| -3% | -$15.6K | ﹤0.01% | 1646 |
|
|
2023
Q3 | $504K | Sell |
18,081
-5,145
| -22% | -$143K | ﹤0.01% | 1644 |
|
|
2023
Q2 | $792K | Buy |
23,226
+10,612
| +84% | +$362K | ﹤0.01% | 1349 |
|
|
2023
Q1 | $379K | Sell |
12,614
-7,747
| -38% | -$233K | ﹤0.01% | 1568 |
|
|
2022
Q4 | $575K | Buy |
20,361
+4,570
| +29% | +$129K | ﹤0.01% | 1266 |
|
|
2022
Q3 | $519K | Sell |
15,791
-18,297
| -54% | -$601K | ﹤0.01% | 1225 |
|
|
2022
Q2 | $1.07M | Buy |
34,088
+25,109
| +280% | +$790K | 0.01% | 800 |
|
|
2022
Q1 | $412K | Sell |
8,979
-7,928
| -47% | -$364K | ﹤0.01% | 1244 |
|
|
2021
Q4 | $1.04M | Sell |
16,907
-6,296
| -27% | -$385K | 0.01% | 801 |
|
|
2021
Q3 | $1.73M | Buy |
23,203
+5,937
| +34% | +$444K | 0.01% | 557 |
|
|
2021
Q2 | $1.6M | Buy |
17,266
+821
| +5% | +$75.9K | 0.01% | 562 |
|
|
2021
Q1 | $1.46M | Buy |
16,445
+10,216
| +164% | +$906K | 0.02% | 551 |
|
|
2020
Q4 | $581K | Buy |
6,229
+5,453
| +703% | +$509K | 0.01% | 780 |
|
|
2020
Q3 | $50K | Buy |
776
+334
| +76% | +$21.5K | ﹤0.01% | 1624 |
|
|
2020
Q2 | $24K | Buy |
+442
| New | +$24K | ﹤0.01% | 1866 |
|